Health
Newer Type 2 diabetes medications have heart and kidney disease benefits, too – Science Codex
DALLAS, Sept. 28, 2020 — Two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease. Based on analyses of the clinical trials through March 2020, a group of leading experts in diabetes, heart failure, kidney disease and cardiometabolic disease believe the medicines should be considered for people with CKD and Type 2 diabetes to pr…
-
General23 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News23 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
Noosa News18 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
Noosa News23 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years